QIAGEN partners with sequencing provider
QIAGEN N.V. announced that it has expanded its relationship with BG to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services.
Under the reseller agreement, BGI customers will receive sequencing data generated from their samples through Ingenuity Variant Analysis‘ secure, cloud-based environment and gain access to its leading comprehensive gene variant data and genomic interpretation applications
“We are very pleased to expand QIAGEN’s relationship with BGI, the global leader in sequencing services. Integrating Ingenuity Variant Analysis into BGI’s highly reliable sequencing services will enable clients to accelerate workflows. They’ll be able to transform large quantities of genomic data into valuable molecular insights for research or clinical applications,” said Laura Furmanski, Head of QIAGEN’s Bioinformatics Business Area. “Bioinformatics solutions from QIAGEN are growing rapidly as scientists and healthcare professionals increasingly use genomic information to guide research and provide precise diagnosis for medical decision-making. We are committed to working with leading organizations such as BGI to make these improvements in life possible.”
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

From handicap to asset: AI approach leverages optics phenomenon to produce better images - The potential e.g. in diagnostics is huge

Globe Diagnostics S.r.l. - Seggiano di Pioltello (Mi), Italy
How recurrent strep A infections affect the brain
Category:Heme-thiolate_proteins
Category:Homeopathic_organizations
First derivation of human embryonic stem cells without exposure to cell feeders
Category:Sleep_researchers
Herpesviridae

Measuring forces in the DNA molecule - First direct measurements of base-pair bonding strength
Category:Uncategorised_pharmacology_articles
